Effects of vitamin E and gemfibrozil on lipid profiles, lipid peroxidation and antioxidant status in the elderly and young hyperlipidemic subjects

Saudi Medical Journal

Volumn 27, Issue 4, 2006, Pages 453-459

  Sutken, Emine ^a   Inal, Mine ^a   Ozdemir, Filiz ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CHOLESTEROL; GEMFIBROZIL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE;

ADULT; AGE FACTORS; AGED; ANTILIPEMIC AGENTS; ANTIOXIDANTS; FEMALE; GEMFIBROZIL; HUMANS; HYPERLIPIDEMIAS; LIPID PEROXIDATION; LIPIDS; MALE; VITAMIN E;

EID: 33645684986     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Benfante R; Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA 1990; 263:393-396.
2. Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Inten Med 1993; 153: 1065-1073.
3. Prasad K, Kalra J. Oxygen-free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 1993; 125: 958-973.
4. Mc Cord JM. Oxygen-free radicals in post-ischemic tissue injury. N Engl J Med 1985; 312:159-163.
5. Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993; 23: 21-48.
6. Rohn TT, Hinds TR, Vincenzi FF. Inhibition of Ca+2- pump ATPase and the Na+/K+-pump ATPase by iron-generated free radicals. Protection by 6,7-dimethyl-2,4-DI-1- pyrrolidinyl-7H-pyrrolo[2,3-d] pyrimidine sulfate (U-89843D), a potent, novel, antioxidant/free radical scavenger. Biochem Pharmacol 1996; 51:471-476.
7. Gokkusu C, Ademoglu E, Turkoglu UM, Oz H, Oz F. Thymosin alpha 1 protects liver and aorta from oxidative damage in atherosclerotic rabbits. Life Sci 1996; 59: 1059-1067.
8. Chow CK. Vitamin E and oxidative stress. Free Radic Biol Med 1991; 11: 215-232.
9. Mazor D, Brill G, Shorer Z, Moses S, Mcyerstein N. Oxidative damage in red blood cells of vitamin E deficient patients. Clin Chim Acta 1997; 8; 265(1): 131-7.
10. Burton GW, Joyce A, Ingold KU. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys 1983; 221: 281-290.
11. Gey KF, Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann NY Acad Sci 1989; 570: 268-282.
12. Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, van Laar A, de Bruin M, et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9 year follow-up study in the Netherlands. Am J Clin Nutr 1987; 45: 462-468.
13. Chen MF, Wang TD, Yeh HT, Hsu HC, Lee YT. Gemfibrozil treatment potentiates oxidative resistance of high density lipoprotein in hypertriglyceridemic patients. Eur J Clin Invest 2001; 31: 707-713.
14. Todd PA, Ward A, Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidemia. Drugs 1988; 36: 314-339.
15. Carlsson CM, Papcke-Benson K, Carnes M, Mc Brides PE, Stein JH. Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults. Drugs Aging 2002; 19: 793-805.
16. Aberg F, Appelkvist EL, Bröjersen A, Eriksson M, Angelin B, Hjem Dallner G. Gemfibrozil-induced decrease in serum ubiquinone and a-and β-tocopherol levels in men with combined hyperlipidemia. Eur J Clin Invest 1998; 28: 235-242.
17. Inal M, Sunal E, Kanbak G, Zeytinoglu S. Effects of postmenopausal hormone replacement and β-tocopherol on the lipid profiles and antioxidant status. Clin Chim Acta 1997; 268: 21-29.
18. Hashim SA, Schuttringer GR. Rapid determination of tocopherol in macro and microquantities of plasma. Results obtained in various nutrition and metabolic studies. Am J Clin Nutr 1966; 19: 137-145.
19. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
20. Beutler E. The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity. J Lab Clin Med 1957; 49: 84-95.
21. Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med 1975; 85: 337-341.
22. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
23. Stahl W, Sies H. Antioxidant defense of vitamin E and C, and carotenoids. Diabetes 1997; 46 Suppl 2: 14-18.
24. Viswanathan M, Bhaktan NM, Rockerbie RA. Effect of dietary supplementation of vitamin E on serum lipid and lipoproteins in rabbits fed a cholesterolemic diet. Int J Vitamin Nutr Res 1979; 49: 370-375.
25. Golod EA. The membrane phospholipid peroxidation and Ca+2 dependent ATPase activity of the microsomal fraction isolated from rat renal tissue in thermal ischemia with and without alpha-tocopherol protection. Urol Nefrol (Mosk) 1997; 5: 5-9.
26. Komaratat P, Chupukcharoen N, Wilariat P. Effect of vitamin E on cholesterol plasma lipoprotein distribution and metabolism in rabbit. Int J Vitam Nutr Res 1985; 55: 167-171.
27. Rezaian GR, Taheri M, Mozaffari BE, Mosleh AA, Ghamlambor MA. The salutary effects of antioxidant vitamins on the plasma lipids of healthy middle aged-to-elderly individuals: a randomized, double-blind, placebo-controlled study. J Med Liban 2002; 50: 10-13.
28. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-1449.
29. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aroma A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139: 1180-119.
30. Wojcicki J, Rozewicka L, Barcew-Wiszniewska B, Samochowie L, Juzwiak S, Kadlubowska D et al. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 1991; 87: 9-16.
31. Losonczy KG, Haris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996; 64: 190-196.
32. Qiao Y, Yokoyama M, Kameyama K, Asano G. Effect of vitamin E on vascular integrity in cholesterol-fed guinea pigs. Arterioscler Thromb 1993; 1885-1892.
33. Takenaka Y, Miki M, Yasuda H, Mino M. The effect of atocopherol as an antioxidant on the oxidation of membrane protein thiolase induced by free radicals generated in different sites. Arch Biochem Biophys 1991; 285: 344-350.
34. Szczeklik A, Gryglewski RJ, Domagala B, Dworski R, Bassista M. Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet agreeability. Thromb Haemost 1985; 54: 425-430.
35. Morel DW, de la Llera-Maya M, Friday KE. Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis. J Nutr 1994; 124: 2123-2130.
36. Takenaka Y, Miki M, Yasuda H, Mino M. The effect of alpha-tocopherol as an antioxidant on the oxidation of membrane protein thiolase induced by free radicals generated in different sites. Arch Biochem Biophys 1991; 285: 344-3450.
37. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999; 27: 916-921.
38. Hsu HC, Lee YT, Yeh HT. Chen MF. Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia. J Lab Clin Med 2001; 137: 414-421.
39. Chen MF, Wang TD, Yeh HT, Hsu HC, Lee YT. Gemfibrozil treatment potentiates oxidative resistance of high density lipoprotein in hypertriglyceridemic patients. Eur J Clin Invest 2001; 31: 707-713.
40. Vasquez M, Zambon D, Hernandez Y, Adzet T, Merlos M, Ros E et al. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidemia. Br J Clin Pharmacol 1998; 45: 265-269.